[ESPR] YoY Quarter Result on 31-Mar-2012 [#Q1]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
30-Mar-2012
Financial Year
2012
Quarter
31-Mar-2012 [#Q1]
Profit Trend
QoQ- 62.68%
YoY-
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
31/03/15 31/03/14 31/03/13 31/03/12 31/03/03 31/03/02 31/03/01 CAGR
Revenue 0 0 0 0 0 0 1 -
PBT -11,466 -7,874 -4,239 -2,449 -7,406 -7,303 -5,981 4.75%
Tax 227 16 803 261 633 314 -976 -
NP -11,466 -7,874 -4,239 -2,449 -7,406 -7,303 -5,981 4.75%
Tax Rate - - - - - - - -
Total Cost 11,466 7,874 4,239 2,449 7,406 7,303 5,982 4.75%
Ratio Analysis
31/03/15 31/03/14 31/03/13 31/03/12 31/03/03 31/03/02 31/03/01 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 -598,100.00 -
Per Share
31/03/15 31/03/14 31/03/13 31/03/12 31/03/03 31/03/02 31/03/01 CAGR
EPS -0.56 -0.51 -0.29 -0.25 -1.76 -1.75 -1.61 -7.26%
EPS Diluted -0.56 -0.51 -0.29 -0.25 -1.76 -1.75 -1.61 -7.26%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.